Coronavirus vaccine in China produces neutralizing antibodies in early-stage trial
May 22, 2020 at 11:49 AM EDT
A potential coronavirus vaccine developed in China appeared to provoke neutralizing antibodies in dozens of patients in an early-stage clinical trial, an important step in developing a vaccine that might provide immunity to Covid-19.
